Erin McEvoy is an Assistant Editor for Cannabis Science and Technology, focusing on the latest developments and research in the field of cannabis science. With a passion for education and advocacy, Erin's articles aim to provide accurate and informative content to readers interested in the medicinal and recreational uses of cannabis.
Preston is the artificial intelligence that powers the Intelligent Relations PR platform. Meet Preston
United States (National)
Not enough data
Erin McEvoy's coverage predominantly revolves around cannabis, with a specific focus on medical cannabis, scientific research, and legal aspects of its use. She cites data and government announcements extensively in her articles.
If you are considering pitching to Erin, ensure that your expertise falls within the realm of healthcare and pharmaceuticals or scientific research related to cannabis. Additionally, she may be interested in receiving information about recent studies, survey findings or legal policy changes regarding medical cannabis use in the United States.
Given her national geographic focus on the United States, pitches should take into account relevant U.S.-specific regulations and developments concerning medical cannabis.
This information evolves through artificial intelligence and human feedback. Improve this profile .
By: Madeline Colli, Erin Mcevoy
In this interview, we discuss the potential of cannabinoids in treating common health conditions in pets.
By: Erin Mcevoy
Overall, the survey revealed that people with chronic pain supported policies expanding medical cannabis access more than physicians.
By: Erin Mcevoy, Madeline Colli
MM411’s president and co-founder, Chris DeVol, discusses the evolution of the company, their most popular cannabis education courses, and their partnership with Cannabis Science and Technology.
By: Madeline Colli, Erin Mcevoy
MM411’s president and co-founder, Chris DeVol, discusses challenges and trends in global cannabis education, plus upcoming initiatives of the company.
By: Erin Mcevoy
Noelle Russell and a panel of experts discussed the present and future uses of Artificial Intelligence in the nutrition industry.
By: Erin Mcevoy
The new hemp regulations, limiting THC levels in products, took effect in September.
By: Erin Mcevoy
This month’s webinar covered research on cannabis studied as a treatment for rheumatic disorders, menstrual symptoms, eczema, and more.
By: Erin McEvoy
The latest addition to Kemin’s line of food safety ingredients inhibits mold growth and is an alternative to synthetic preservatives.
By: Erin Mcevoy, Madeline Colli
On November 5, 2024, Floridians will decide on Amendment 3, which proposes legalizing recreational cannabis. Former President Trump has stated support for this measure, aligning with his stance on state-level cannabis policies.
By: Erin Mcevoy
Several surveys from 2024 reveal data and characteristics of adult American cannabis usage and opinions.
(833) 317-6278 
